COVID-19: Toxicities of Potential Therapies

May 13, 2020 00:21:18
COVID-19: Toxicities of Potential Therapies
Critical Care Perspectives in Emergency Medicine
COVID-19: Toxicities of Potential Therapies

May 13 2020 | 00:21:18

/

Show Notes

Currently, there is no approved treatment or proven therapy for COVID-19. As such, many have turned to treatments with little to no supporting evidence. In this podcast, we bring back EM Pharmacy extraordinaire Bryan Hayes to discuss information on the toxicities of potential therapies used in the management of patients with COVID-19.

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

November 17, 2017 00:27:56
Episode Cover

Mechanical Circulatory Support Devices

What do you do for the patient in cardiogenic shock who is not responding to vasopressors and inotropes?  Should you place a mechanical circulatory...

Listen

Episode 0

October 21, 2022 00:18:32
Episode Cover

Does the Timing of Source Control in Sepsis Make a Difference?

The emergency department resuscitation of patients with sepsis focuses on early recognition, timely administration of appropriate antibiotics, appropriate fluid resuscitation, early vasopressor initiation for...

Listen

Episode

July 09, 2024 00:26:28
Episode Cover

Should We Use NIPPV for Preoxygenation for All Intubations?

Over 1 million critically ill patients are intubated each year in the US.  Hypoxemia occurs in up to 20% of patients and can lead...

Listen